NT5E and lung adenocarcinoma: These data point to CD73, as a tumor-associated antigen, being a viable target and mediating potent CAR-NK cell based anti-tumor effects against CD73+ lung adenocarcinoma xenografts in mice, both in terms of tumor metabolism and mouse survival.